Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-26 @ 1:17 PM
Ignite Modification Date:
2025-12-26 @ 1:17 PM
NCT ID:
NCT06924606
Brief Title:
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
Official Title:
A Phase II Clinical Study of JS207 (PD-1/VEGF Dual Antibody) Combined With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer After Progression Following Platinum-based Chemotherapy and Immunotherapy
Study:
NCT06924606
Protocol Section:
NCT06924606